Fr. Emmanuel Lemelson Comments on US Supreme Court Decision

Lemelson Capital Chief Comments on Unprecedented 9-year SEC Fight over Ligand Pharmaceuticals (NASDAQ: LGND) Jerricho, New York, December 12, 2023 — Rev. Emmanu...